• 2019 Senior Report Senior Report: Older Americans have more options for home care, but still struggling.

    The United Health Foundation has released results of a sweeping new study benchmarking the health of older adults. The America's Health Rankings® Senior Report was created in partnership with GAPNA to improve the health of America's seniors.

    The data will help advanced practice nurses and other providers deliver quality care.

    Find out about it!

  • FREE continuing education credit is available for the following session:

    "Decisional Capacity"

    (session captured at the GAPNA 2018 Annual Conference)


    For July/August 2019 - Get Your Free CNE Now!

  • Save $90 - Register Now with Early Bird Savings!
    38th Annual GAPNA Conference

    October 3-5, 2019 at the Paris Hotel, Las Vegas, NV.

    Focused education; lasting connections, networking, free access to the GAPNA Online Library.

    Earn up to 22 contact hours (including pre-conference workshops).

    Get more information and register now!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

Studies Link Adverse Drug Interactions to Elevated Risk for Hospitalization Among the Elderly

A review of 17 studies that assessed specific drug interactions in elderly patients found that 16 of the studies reported an elevated risk for hospitalization in older adults associated with drug interactions.

These interactions included angiotensin-converting enzyme (ACE) inhibitors and potassium-sparing diuretics; ACE inhibitors or angiotensin receptor blockers and sulfamethoxazole/trimethoprim (SMX/TMP); benzodiapines or zolpidem and other medications; calcium channel blockers and macrolide antibiotics; digoxin and macrolide antibiotics; lithium and loop diuretics or ACE inhibitors; phenytoin and SMX/TMP; sulfonylureas and antimicrobial agents; theophylline and ciprofloxacin; and warfarin and antimicrobial agents or non-steroidal anti-inflammatory drugs.

The researchers concluded that when the elderly receive drug therapy, it should be absolutely necessary for the achievement of well-defined goals. They also recommend that an evidence-based, high-priority list of drug interactions in the elderly be developed and maintained.

For more info, see Hines, L.E. et al. (2011). Potentially harmful drug-drug interactions in the elderly: A review. American Journal of Geriatric Pharmacotherapy, 9, 364-377.

Related Topic 1: 

GAPNA Newsletter Issue: 

VIEW ALL ARTICLES: